Vaccine Maker Named In Investor Class Action Over Production Misstatements

Mealey's (June 10, 2021, 9:15 AM EDT) -- GREENBELT, Md. — Vaccine manufacturer Emergent BioSolutions Inc. and certain of its current and former senior executives violated federal securities laws by misrepresenting the company’s ability to manufacture millions of doses...

To view the full article, register now.